Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use

по Dalhoff, Axel
Опубликовано 2012

Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients

по Dalhoff, Axel
Опубликовано 2014

Seventy-Five Years of Research on Protein Binding

по Dalhoff, Axel
Опубликовано в: Antimicrob Agents Chemother (2018)

Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?

по Dalhoff, Axel
Опубликовано в: Infection (2020)

Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?

по Dalhoff, Axel
Опубликовано в: Infection (2020)

Activity of Moxifloxacin, Imipenem, and Ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in Monocultures and Mixed Cultures...

по Schubert, Sabine, Dalhoff, Axel
Опубликовано 2012

Comparative In Vitro Activities of the Novel Antibacterial Finafloxacin against Selected Gram-Positive and Gram-Negative Bacteria Tested in Mueller-Hinton Broth and Synthetic Urine

по Dalhoff, Axel, Stubbings, Will, Schubert, Sabine
Опубликовано 2011

In Vitro Susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, Trovafloxacin, and Ciprofloxacin

по Hoppe, Jörg E., Dalhoff, Axel, Pfründer, Dietmar
Опубликовано 1998

Alternative Strategies for Proof-of-Principle Studies of Antibacterial Agents

по Dalhoff, Axel, Weintraub, Andrej, Nord, Carl Erik
Опубликовано 2014

Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections

по Taubert, Max, Lückermann, Mark, Vente, Andreas, Dalhoff, Axel, Fuhr, Uwe
Опубликовано в: Antimicrob Agents Chemother (2018)

Early Clinical Assessment of the Antimicrobial Activity of Finafloxacin Compared to Ciprofloxacin in Subsets of Microbiologically Characterized Isolates

по Vente, Andreas, Bentley, Christine, Lückermann, Mark, Tambyah, Paul, Dalhoff, Axel
Опубликовано в: Antimicrob Agents Chemother (2018)

Effects of Amoxicillin, Gentamicin, and Moxifloxacin on the Hemolytic Activity of Staphylococcus aureus In Vitro and In Vivo

по Worlitzsch, Dieter, Kaygin, Hayal, Steinhuber, Andrea, Dalhoff, Axel, Botzenhart, Konrad, Döring, Gerd
Опубликовано 2001

Degradation of Ciprofloxacin by Basidiomycetes and Identification of Metabolites Generated by the Brown Rot Fungus Gloeophyllum striatum

по Wetzstein, Heinz-Georg, Stadler, Marc, Tichy, Hans-Volker, Dalhoff, Axel, Karl, Wolfgang
Опубликовано 1999

Novel Pharmacokinetic-Pharmacodynamic Model for Prediction of Outcomes with an Extended-Release Formulation of Ciprofloxacin

по Meagher, Alison K., Forrest, Alan, Dalhoff, Axel, Stass, Heino, Schentag, Jerome J.
Опубликовано 2004

Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers

по Taubert, Max, Chiesa, Joseph, Lückermann, Mark, Fischer, Carsten, Dalhoff, Axel, Fuhr, Uwe
Опубликовано в: Antimicrob Agents Chemother (2017)

Moxifloxacin and Azithromycin but not Amoxicillin Protect Human Respiratory Epithelial Cells against Streptococcus pneumoniae In Vitro when Administered up to 6 Hours after Challen...

по Ulrich, Martina, Albers, Cordula, Möller, Jan-Georg, Dalhoff, Axel, Korfmann, Gisela, Künkele, Frank, Döring, Gerd
Опубликовано 2005